American Journal of Clinical Oncology
-
Publication Venue For
-
Ra-223 Treatment for Bone Metastases in Castrate-Resistant Prostate Cancer: Practical Management Issues for Patient Selection..
42:399-406.
2019
-
Survival Benefit of Adjuvant Radiation Therapy in Node-positive Vulvar Cancer..
41:845-850.
2018
-
Chemoradiation Versus Chemotherapy in Uterine Carcinosarcoma: Patterns of Care and Impact on Overall Survival..
41:784-791.
2018
-
Definitive Stereotactic Body Radiotherapy (SBRT) for Extracranial Oligometastases: An International Survey of >1000 Radiation Oncologists..
40:418-422.
2017
-
The Benefit of Chemotherapy in Esophageal Cancer Patients With Residual Disease After Trimodality Therapy..
39:136-141.
2016
-
The Effect of Receiving Treatment Within a Clinical Trial Setting on Survival and Quality of Care Perception in Advanced Stage Non-Small Cell Lung Cancer..
39:126-131.
2016
-
Management of Postprostatectomy Biochemical Relapse With Salvage Radiotherapy: Results of an International Survey..
39:64-68.
2016
-
Pain Intensity and Pain Interference in Patients With Lung Cancer: A Pilot Study of Biopsychosocial Predictors..
38:457-464.
2015
-
Adjuvant versus salvage radiation therapy for prostate cancer patients with adverse pathologic features: comparative analysis of long-term outcomes..
38:55-60.
2015
-
Pain intensity and pain interference in patients with lung cancer: A pilot study of biopsychosocial predictors.
38:457-464.
2015
-
Radiation therapy in the treatment of minor salivary gland tumors..
37:492-497.
2014
-
Combined-modality therapy for rectal cancer: analysis of potential differences in disease presentation, treatment adherence, and treatment outcome according to race..
37:122-125.
2014
-
Factors associated with use of preoperative chemoradiation therapy for rectal cancer in the Cancer Care Outcomes Research and Surveillance Consortium..
36:572-579.
2013
-
Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma.
36:589-595.
2013
-
Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma..
36:589-595.
2013
-
Adherence to adjuvant hormonal therapy and its relationship to breast cancer recurrence and survival among low-income women..
36:181-187.
2013
-
Complication rates in patients with negative axillary nodes 10 years after local breast radiotherapy after either sentinel lymph node dissection or axillary clearance..
36:12-19.
2013
-
Adherence to adjuvant hormonal therapy and its relationship to breast cancer recurrence and survival among low-income women.
36:181-187.
2013
-
Complication rates in patients with negative axillary nodes 10 years after local breast radiotherapy after either sentinel lymph node dissection or axillary clearance.
36:12-19.
2013
-
Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field Radiotherapy and concurrent chemotherapy.
37:433-437.
2013
-
Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy
2013
-
Weekly paclitaxel and carboplatin induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck..
35:6-12.
2012
-
Concurrent chemotherapy and intensity-modulated radiotherapy for organ preservation of locoregionally advanced oral cavity cancer..
34:356-361.
2011
-
S9511: a Southwest Oncology Group phase II study of trimetrexate, 5-fluorouracil, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach..
33:117-120.
2010
-
Surveillance, Epidemiology, and End Results (SEER) database analysis of microcystic adnexal carcinoma (sclerosing sweat duct carcinoma) of the skin..
33:125-127.
2010
-
Cetuximab, paclitaxel, carboplatin, and radiation for head and neck cancer: A toxicity analysis.
33:144-147.
2010
-
Paraganglioma of the head and neck: long-term local control with radiotherapy..
32:304-307.
2009
-
A phase II trial of denileukin diftitox in patients with previously treated advanced non-small cell lung cancer.
32:269-273.
2009
-
Image-guided percutaneous thermal ablation for the palliative treatment of chest wall masses.
30:361-367.
2007
-
Phase II trial of gemcitabine plus irinotecan in patients with esophageal cancer: a Southwest Oncology Group (SWOG) trial..
29:116-122.
2006
-
Cyclooxygenase-2 (COX-2) levels before and after chemotherapy: a study in rectal cancer..
28:560-564.
2005
-
A low rate of central nervous system progression in a phase II trial of outpatient chemobiologic therapy with cisplatin, temozolomide, interleukin-2, and interferon alfa 2-B for metastatic malignant melanoma..
28:479-484.
2005
-
Evaluation of the effect of age on treatment-related mortality and relapse in patients with high-risk primary breast cancer receiving high-dose chemotherapy..
28:248-254.
2005
-
Radiation dose considerations in the palliative treatment of locally advanced adenocarcinoma of the pancreas..
28:227-233.
2005
-
A phase III trial evaluating the combination of cisplatin, etoposide, and radiation therapy with or without tamoxifen in patients with limited-stage small cell lung cancer: Cancer and Leukemia Group B Study (9235)..
28:81-90.
2005
-
Economic evaluation of zoledronic acid versus pamidronate for the prevention of skeletal-related events in metastatic breast cancer and multiple myeloma..
28:8-16.
2005
-
A phase II study of single agent gemcitabine in relapsed or refractory follicular or small lymphocytic non-Hodgkin lymphomas: A hoosier oncology group study.
28:169-172.
2005
-
Cyclooxyqenase-2 (COX-2) levels before and after chemotherapy: A study in rectal cancer.
28:560-564.
2005
-
Phase II trial of vinorelbine plus doxorubicin in relapsed small-cell lung cancer: CALGB 9332..
27:19-23.
2004
-
Cyclooxygenase-2 (COX-2) expression in human meningioma as a function of tumor grade..
26:S98-102.
2003
-
Selection of patients with melanoma brain metastases for aggressive treatment..
26:354-357.
2003
-
Neoadjuvant doxil chemotherapy prior to androgen ablation plus radiotherapy for high-risk localized prostate cancer: feasibility and toxicity..
26:312-316.
2003
-
Low-dose radiation for posttransplant lymphoproliferative disorder..
26:210-214.
2003
-
Phase II study of MGI-114 administered intravenously for 5 days every 28 days to patients with metastatic colorectal cancer..
26:132-134.
2003
-
Phase II study of dolastatin-10 as first-line treatment for advanced colorectal cancer..
25:451-453.
2002
-
The corporate presence at oncology meetings..
25:535-536.
2002
-
Metastatic dedifferentiated chordoma with elevated beta-hCG: a case report..
25:274-276.
2002
-
Irinotecan treatment for recurrent malignant glioma using an every-3-week regimen..
25:204-208.
2002
-
Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer..
24:107-112.
2001
-
Phase II study of intravenous CI-958 in metastatic colorectal adenocarcinoma..
23:602-604.
2000
-
Adjuvant sequential chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil (ACMF) with concurrent radiotherapy in resectable advanced breast cancer..
23:122-127.
2000
-
Tumor lysis syndrome and acute renal failure after treatment of non-small-cell lung carcinoma with combination irinotecan and cisplatin..
21:426-429.
1998
-
Phase II trial of intravenous CI-980 (NSC 370147) in patients with metastatic colorectal carcinoma. Model for prospective evaluation of neurotoxicity..
20:573-576.
1997
-
A phase II study of cisplatin, 5-fluorouracil, leucovorin, and etoposide in advanced non-small-cell lung cancer..
20:128-131.
1997
-
Phase I trial of etoposide, carboplatin, and GM-CSF in extensive small-cell lung cancer: a Cancer and Leukemia Group B study (CALGB 8832)..
20:24-30.
1997
-
Neck failure in T2N0 squamous cell carcinoma of the true vocal cords: The Fox Chase experience and review of the literature.
20:154-157.
1997
-
Phase II study of docetaxel in advanced soft tissue sarcomas..
19:574-576.
1996
-
Late onset of isolated central nervous system metastasis of liposarcoma--a case report..
19:351-355.
1996
-
Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findings..
19:416-421.
1996
-
Pilot phase II trial of 13-cis-retinoic acid and interferon-alpha combination therapy for advanced pancreatic adenocarcinoma..
18:525-527.
1995
-
A phase II study of tamoxifen combined with cisplatin-interleukin 2 and alpha-interferon in metastatic melanoma..
18:421-424.
1995
-
Phase II trial of isotretinoin and recombinant interferon alfa-2a in metastatic colorectal carcinoma..
18:436-438.
1995
-
A phase II study of recombinant interferon-gamma following combination chemotherapy for patients with extensive small cell lung cancer. CALGB..
18:67-70.
1995
-
Lorazepam-enhancement of the antiemetic efficacy of dexamethasone and promethazine. A placebo-controlled study..
17:417-421.
1994
-
Nongenital granuloma inguinale in an oncology patient..
17:456-460.
1994
-
The Bird's Nest Filter. An alternative to long-term oral anticoagulation in patients with advanced malignancies..
17:115-117.
1994
-
An analysis of radiotherapy data from the CNS cancer consortium's randomized prospective trial comparing AZQ to BCNU in the treatment of patients with primary malignant brain tumors. The CNS cancer consortium..
16:277-283.
1993
-
Extramedullary plasmacytoma of the pancreas..
16:363-368.
1993
-
Phase II evaluation of iproplatin in patients with advanced gastric and pancreatic cancer..
15:524-527.
1992
-
Intensive etoposide and carboplatin chemotherapy for advanced non-small-cell lung cancer. A phase II trial of the Cancer and Leukemia Group B..
15:399-404.
1992
-
Fotemustine (S 10036) in the intra-arterial treatment of liver metastasis from malignant melanoma. A phase II Study..
14:400-404.
1991
-
Metastatic adenocarcinomas of unknown primary site. Prognostic variables and treatment results..
13:55-60.
1990
-
A phase II trial of streptozotocin and adriamycin in advanced APUD tumors..
11:490-495.
1988
-
Biological and clinical aspects of hyperthermia in cancer therapy..
11:368-380.
1988
-
Coital risk factors for cervical cancer. Sexual activity among white middle class women..
10:222-226.
1987
-
Evaluation of new anticancer agents against human pancreatic carcinomas in nude mice..
10:219-221.
1987
-
High-dose amsacrine (AMSA) therapy of relapsed and refractory adult acute nonlymphocytic leukemia. A phase II study..
7:361-363.
1984
-
Scanning with L-(13 N) glutamate: Assessment of the response to chemotherapy of a patient with embryonal rhabdomyosarcoma..
5:285-289.
1982
-
Hexamethylmelamine and prednisone in the treatment of refractory multiple myeloma..
5:21-27.
1982